ArchivesMagazine - 15 Jun 2023Biotech companies in demand as pharmaceutical companies spend billions on takeovers Big drug companies are eager to gain access to new treatments 15 June 2023|News|by Martin Gamble Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < Are parts of your portfolio not doing well? Here’s why that can be healthy The time looks right to book into hotel operator Whitbread again > Issue: 15 Jun 2023 - Page 8 | Contents Next: The time looks right to book into hotel operator Whitbread again Previous: Are parts of your portfolio not doing well? Here’s why that can be healthy Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Martin Gamble Issue Contents Ask Tom Can a retrospective lifetime allowance assessment be made once in drawdown? Editor's View Are parts of your portfolio not doing well? Here’s why that can be healthy Education Five key ratios to analyse a stock in five minutes Exchange-Traded Funds Fad or genuine trend? What you need to know before investing in a thematic ETF Feature Strike it rich: three oil and gas stocks with big opportunities Great Ideas The time looks right to book into hotel operator Whitbread again Bargain shares: Next 15 at a 40% discount to its 10-year average valuation The story behind a 27% advance in DiscoverIE shares since last August News UK banks’ profit margins under threat as pressure grows to boost rates on savings accounts What El Niño means for commodity markets and how to play strong crop prices Biotech companies in demand as pharmaceutical companies spend billions on takeovers Gym Group faces macroeconomic headwinds and consumer behaviour shift Personal Finance Why your pension provider will soon warn you about holding too much cash Russ Mould Reasons why the market could be too pessimistic about oil demand Sector Reports Is the post-Covid luxury goods boom coming to an end? Week Ahead Week Ahead Diary
